Industri Jamu dan Farmasi Sido Muncul Tbk PT operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Industri Jamu dan Farmasi Sido Muncul Tbk PT with three other
pharmaceutical manufacturers in Asia:
Jinghua Pharmaceutical Group Co Ltd
sales of 1.35 billion Chinese Renmimbi [US$191.01 million]
of which 92%
was Medicine Industry),
J B Chemicals and Pharmaceuticals Ltd
(14.14 billion Indian Rupees [US$197.86 million]
of which 100%
was Pharmaceuticals), and
Huaren Pharmaceutical Co Ltd
based in China
(1.38 billion Chinese Renmimbi [US$195.12 million]
of which 93%
was Medicine Industry).
During the year ended December of 2018, sales at
Industri Jamu dan Farmasi Sido Muncul Tbk PT were 2.76 trillion Indonesian Rupiahs (US$195.92 million).
increase of 7.4%
versus 2017, when the company's sales were 2.57 trillion Indonesian Rupiahs.
This was the fourth straight year of sales growth at Industri Jamu dan Farmasi Sido Muncul Tbk PT.
Sales of Pharmacy saw an increase
13.2% in 2018, from
88.52 billion Indonesian Rupiahs to 100.18 billion Indonesian Rupiahs.